ANIXA BIOSCIENCES, INC. Secured Debt, Current
ANIXA BIOSCIENCES, INC. (ANIX) had Secured Debt, Current of $2.00 million as of 2017-07-31, per its 10-Q filed 2017-09-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:SecuredDebtCurrent · last filed 2017-09-08
- 2017-07-31: Secured Debt, Current $2.00M.
- 2017-04-30: Secured Debt, Current $3.00M.
- 2017-01-31: Secured Debt, Current $3.00M.
| Period end | Secured Debt, Current |
|---|---|
| 2017-07-31 | $2.00M 10-Q · filed 2017-09-08 |
| 2017-04-30 | $3.00M 10-Q · filed 2017-05-26 |
| 2017-01-31 | $3.00M 10-Q · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |